SCHEMBL22947433

SCHEMBL22947433

c1ccc(-c2nc(-c3cccnc3)nc(-c3ccccc3-c3cccc4c3-c3ccccc3S4(c3ccccc3)c3ccccc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
MAPT P10636 6/20 0.40
TSHR P16473 4/20 0.40
POLB P06746 2/20 0.40
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CLK4 Q9HAZ1 3/20 0.38
KMT2A Q03164 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
MEN1 O00255 1/20 0.38
GLA P06280 1/20 0.38
SMN1; SMN2 Q16637 7/20 0.38
KDM4E B2RXH2 5/20 0.38
HPGD P15428 5/20 0.38
RAB9A P51151 3/20 0.38
TP53 P04637 4/20 0.37
NPC1 O15118 3/20 0.36
HSD17B10 Q99714 3/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22949646 0.95 ALDH1A1 (0.41) ALDH1A1MAPTTSHRPOLBCYP1A2
SCHEMBL22947430 0.92 ALDH1A1 (0.43) ALDH1A1MAPTTSHRPOLBCYP1A2
SCHEMBL22947426 0.90 ADORA2A (0.38) ALDH1A1MAPTTSHRPOLBKMT2A
SCHEMBL22949087 0.89 SMN1; SMN2 (0.38) ALDH1A1MAPTTSHRPOLBCYP1A2
SCHEMBL22949531 0.87 ADORA3 (0.36) ALDH1A1MAPTTSHRPOLBKMT2A
SCHEMBL22947384 0.85 ADORA2A (0.40) ALDH1A1MAPTTSHRPOLBKMT2A
SCHEMBL22947375 0.84 SMN1; SMN2 (0.40) ALDH1A1MAPTTSHRPOLBCYP1A2
SCHEMBL22948448 0.83 TSHR (0.37) ALDH1A1MAPTTSHRPOLBKMT2A
SCHEMBL22949661 0.83 KDM4E (0.43) ALDH1A1MAPTTSHRSMN1; SMN2KDM4E
SCHEMBL22949634 0.82 ADORA3 (0.38) ALDH1A1MAPTTSHRPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 ALDH1A1 752/4885MAPT 3103/4885TSHR 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.